efficacy and safety of various aspirin doses in patients with ST-segment myocardial infarction undergoing primary percutaneous coronary interventio
Phase 2
- Conditions
- ST-segment elevation myocardial infarction (STEMI).Acute myocardial infarction
- Registration Number
- IRCT2014122220392N1
- Lead Sponsor
- Vice chancellor for research, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 175
Inclusion Criteria
patients with ST-segment myocardial infarction who underwent primary PCI within 12 hours of the onset of heart attack.
Exclusion Criteria
patients with a history of gastrointestinal bleeding and hemorrhagic stroke; opium and alcohol abusers, patients with coagulopathies or history of anticoagulant therapy ; major surgery within 6 weeks; platelets less than 100,000/ microliter; hematocrit less than 25%; creatinine more than 4 mg/dl
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiovascular outcome. Timepoint: one month and one year after the study. Method of measurement: telephone interview and echcardiogarphy for patients with primary outcome.
- Secondary Outcome Measures
Name Time Method Major bleeding. Timepoint: one month and one year after primary PCI. Method of measurement: telephone interview.